Jason Carroll
Chief Executive Officer at TRYPTAMINE THERAPEUTICS LIMITED
Net worth: 15 $ as of 2024-04-29
Profile
Jason Carroll currently works at Tryp Therapeutics, Inc., as Chief Executive Officer from 2023.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TRYP THERAPEUTICS, INC.
0.00% | 2023-11-19 | 325 ( 0.00% ) | 15 $ | 2024-04-29 |
Jason Carroll active positions
| Companies | Position | Start |
|---|---|---|
| TRYPTAMINE THERAPEUTICS LIMITED | Chief Executive Officer | 2023-09-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
- Stock Market
- Insiders
- Jason Carroll
